Jun 6, 2022

Medtronic Announces Dr. Ashwini Sharan Joins Neuromodulation Operating Unit As Chief Medical Officer

adding value

Medtronic plc, a global leader in healthcare technology, today announced that Dr. Ashwini (Ash) Sharan has joined the company’s Neuromodulation Operating Unit as Chief Medical Officer. Dr. Sharan will play a key role in shaping the strategic direction of our innovation and clinical evidence plans, help guide physician, society, and education engagements, serve as a medical advisor to the business, and interact with the medical community to identify current and future business opportunities to address unmet medical needs.

adding value

Dr. Sharan has 25 years of experience and is one of the top neurosurgeons in the United States. He is highly sought after in terms of both his practice and thought leadership in the neurosurgical space. He has an MD from Rutgers New Jersey Medical School and a master’s in population health quality improvement. He currently serves as Co-Director of the Neuro Restoration Center and Professor of Neurological Surgery and Neurology at Thomas Jefferson University, Jefferson Medical College, and previously held roles of President for both the Congress of Neurological Surgeons and the North American Neuromodulation Society.   

“Medtronic is privileged to welcome such a renowned physician to our business, and we look forward to Dr. Sharan’s many contributions in his new role as we look to further build upon our strong innovation and evidence strategy and expand access to our underserved patient populations,” said Nnamdi Njoku, president of Medtronic’s Neuromodulation Operating Unit.

Michelle Claypool
Public Relations